Robyn M. Scherber
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Eosinophilic Disorders and Syndromes, Chronic Myeloid Leukemia Treatments, Kruppel-like factors research
Most-Cited Works
- → The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients(2011)333 cited
- → Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide(2017)165 cited
- → Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development(2015)122 cited
- → Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis(2015)117 cited
- → The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies(2018)117 cited
- → Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients(2014)90 cited
- → Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis(2020)76 cited
- → Avapritinib versus Placebo in Indolent Systemic Mastocytosis(2023)69 cited
- → Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group(2016)69 cited
- → Comprehensively understanding fatigue in patients with myeloproliferative neoplasms(2015)69 cited